0000000000009595
AUTHOR
Ciaccio M.
Erratum: Corrigendum to “Procalcitonin and community-acquired pneumonia (CAP) in children” (Clinica Chimica Acta (2015) 451(Part B) (215–218) (S0009898115004404) (10.1016/j.cca.2015.09.031))
The authors regret that the authors’ names in the original article appear, as reported, in the wrong form, which follows: Bivona Giulia, Agnello Luisa, Scazzone Concetta, Lo Sasso Bruna, Bellia Chiara, Ciaccio Marcello. The correct form is: Giulia (first name) Bivona (last name), Luisa (first name) Agnello (surname), Concetta (first name) Scazzone (surname), Bruna (first name) Lo Sasso (surname), Chiara (first name) Bellia (surname), Marcello (first name) Ciaccio (last name). The authors would like to apologise for any inconvenience caused.
Galectin-3 and Lp(a) plasma concentrations and advanced carotid atherosclerotic plaques: Correlation with plaque presence and features
Introduction: atherosclerosis is one of the leading causes of death and morbidity worldwide. It consists in the development of plaques in the intima media layers of arteries due to lipid accumulation and oxidation, causing massive inflammation. We aim to better understand the role of Galectin-3 (Gal-3) and Lipoprotein(a) [Lp(a)] as possible peripheral markers of plaque presence. Methods: Gal-3 and Lp(a) were measured in plasma samples from 99 patients undergoing carotid endarterectomy and 78 healthy controls, by immunometric assays. Plaques were classified histologically, according to the American Heart Association (AHA) guidelines as type Va (fibroatheroma), Vb (mainly calcific) and Vl (co…
Improving appropriateness in laboratory medicine: How, when and why
The issue of the appropriateness in laboratory medicine has been discussed from several years in association to the parallel onset of two aspects: 1) the significant increase in tests demand and utilization, thanks to the development of laboratory automation and information laboratory systems (LIS), that allow to provide timely and reliable results to clinicians; 2) the opportunity, thanks to new pathophysiological knowledge and new technologies to introduce new and more sophisticated tests in clinical practice, providing a relevant support to the clinician in the management of patients, according to the improved vision of personalized medicine. As a consequence, the potential inappropriate…